Information
-
Patent Grant
-
6530903
-
Patent Number
6,530,903
-
Date Filed
Thursday, February 22, 200123 years ago
-
Date Issued
Tuesday, March 11, 200321 years ago
-
Inventors
-
-
Examiners
Agents
-
CPC
-
US Classifications
Field of Search
US
- 604 220
- 604 110
- 604 195
- 604 187
- 604 111
- 604 181
- 604 192
- 604 197
- 604 198
- 604 218
- 604 228
-
International Classifications
-
Abstract
A safety syringe comprising a casing having a neck and a plunger having a distal portion, a weak portion, and a coupling portion covered by a hollow stopper having a membrane. The plunger is channeled in the casing and is moveable between an extended position and a compressed position. A needle holder, in the neck, contains a distally facing arrowhead and a proximally facing needle. Moving the plunger from an extended position to a compressed position, causes the arrowhead to puncture the membrane and engage the coupling portion. If the plunger is returned to the extended position, the needle is drawn into the casing and the distal portion of the plunger can be removed. If the plunger is re-compressed, the needle encounters a wall in the neck preventing the needle from exiting the casing. The syringe is easy to manufacture and prevents manufacturing burrs from being injected into patients.
Description
BACKGROUND OF THE INVENTION
This application claims priority to, and incorporates by reference, Chinese Patent Application No. 00205827.8 filed on Feb. 24, 2000.
1. Field of the Invention
The present invention relates to a syringe, particularly, to a safety syringe, belonging to the medical device technical field. Safety syringes are designed for one-time use and are, therefore, not re-useable.
2. Background of the Art
In the medical field, there is a great need to avoid cross-contamination or infection which may be caused when a syringe is used more than once. Single use syringes have long been thought as being one way to avoid these potential problems. However, current single use syringes present a variety of problems. Some syringes which claim to be “single use” in actuality can be reused with user intervention. Some syringes are designated as “single use” solely because they are to be discarded after use pursuant to a regulation; nothing prevents their reuse. Some syringe designs expose the drug or bodily fluid contained therein to reactive components of the syringe (e.g. a spring used to retract the plunger). In addition, some syringes, although not capable of being reused, present health risks to the medical personnel handling them. Accordingly, there is a need for a single use syringe which is: (a) easy to use; (b) incapable of being reused; (c) presents little or no danger to medical personnel after use; (d) designed in such a way as to prevent contact between reactive syringe components and the fluid contained within the syringe; and (e) capable of being manufactured at low cost.
Currently, there are mainly two classes of safety syringes. One class of syringes, which employs a spring to retract a needle into the syringe, is represented in U.S. Pat. Nos. 5,769,822, 5,980,494, and 6,039,713. Although these syringes are effective and easy to use, the also have inherent disadvantages. First, the spring-loaded structure is complicated because of the number of parts involved creates difficulties in constructing the syringe. Second, due to the complicated structure, the costs of manufacturing are high making marketing difficult. Third, due to the location of the spring at the needle end of the syringe, it is difficult to position the fluid close to the inlet to the needle; this increases fluid residue and makes removal of air bubbles more difficult.
The second class of syringes employs a locking mechanism on the plunger which engages a corresponding structure at the base of the needle when the plunger is completely compressed. A subsequent withdrawal of the plunger pulls the needle into the syringe barrel. The structure of these syringes is simpler and the cost of production lower in comparison to the former class. However, this class of syringes also has disadvantages. For example, in Chinese Patent CN2270509Y, the corresponding parts of the locking mechanism between the needle and the plunger are exposed to fluid contained within the syringe. Accordingly, any burrs on the parts which result from manufacturing may fall into the fluid and be thereafter accidentally transmitted to the patient giving rise to a potentially dangerous situation. In addition, in many of these syringes, the locking mechanism can be disengaged and the syringe reused.
U.S. Pat. No. 5,601,534 discloses a one-time-use safety syringe comprising a simple structure which reliably releases gases and retains a very small amount of residual fluid. However, it also presents disadvantages. The structure employs an inward facing needle extension which is bent by an arrowhead attached to the plunger. The extension is bent into a cavity in the plunger such that when the plunger is pulled away from the needle, the needle is pulled into the syringe barrel.
A first disadvantage is that the size of the extension must correspond to the size of the needle; a large needle requires a large extension which is not as easily bent thereby degrading the integrity of the engagement with the plunger.
A second disadvantage is that the rubber stopper, which houses the cavity, is solid. Due to the solid nature of the stopper, the extension must completely pierce the stopper to create a strong engagement with the cavity. To create this strong engagement requires a strong compression of the plunger at the completion of the injection; this can be difficult when the needle and needle extension are large.
A third disadvantage results with large needles. A large compressive force needs to be applied to the plunger to complete an injection with a large needle. This force counteracts the force necessary for the needle extension to puncture the plunger. To address this problem, the needle's engagement with the barrel head needs to enhanced. However, by enhancing the needle's engagement with the barrel head, it becomes more difficult to withdraw the needle into the syringe barrel after the injection is complete.
Fourth, the engagement of the needle extension and the plunger is such that upon withdrawal of the needle into the syringe barrel, residual fluid in the barrel can leak out of the syringe.
Fifth, the size of the plunger cavity corresponds to the size of the needle. Accordingly, one plunger can not be used with a variety of needle sizes. Therefore, medical personnel must maintain an inventory of various sizes of plungers which is costly and which occupies precious storage space.
SUMMARY
A solution to the aforementioned deficiencies in the art are resolved by the safety syringe herein described. Specifically, the presently described syringe has the following advantages over the prior art: (a) the hooks within the stopper which engage the arrowhead are not in contact with the fluid contained in the syringe thereby reducing the potential for manufacturing burrs to fall into the fluid and thereby be injected into the patient. The structure is possible because the engagement of the needle holder and the plunger occurs when the arrowhead pierces the stopper membrane. After the completion of the injection thereby establishing this engagement, the syringe can not be reused. Moreover, the puncturing of the membrane requires a force which is much smaller than the force necessary to compromise the o-ring seal in the plunger neck; accordingly the counteractive force problems in the prior art are eliminated; (b) the o-ring positioned in the syringe neck prevents fluid from escaping when the needle is initially pulled toward the syringe barrel; (c) the syringe has a simple structure which is both easy to use and manufacture; (d) the cavity in the stopper and the arrowhead can be used with any size needle (i.e. the size of the cavity and the arrowhead is not dependent on the size of the needle); and (e) the size of the needle does not compromise the integrity of the locking between the plunger and the needle holder.
These and other advantages are made possible by a safety syringe comprising a syringe casing having a distal end and a proximal end. A plunger is channeled in the syringe casing and is capable of moving from an extended position to a compressed position. The plunger has a weak portion, a distal portion, and a coupling portion. A stopper, having a membrane, is affixed to the coupling portion of the plunger; the membrane is between the proximal end of the syringe casing and the plunger. A needle holder, initially coupled to the proximal end of the syringe casing, has a distally facing arrowhead and a proximally facing needle. When the plunger is moved from the extended position to the compressed position, the arrowhead punctures the membrane and lockingly engages the coupling portion of the plunger. Subsequently, when the plunger is returned to the extended position, the needle holder and needle are drawn into an interior of the syringe casing.
In the safety syringe above-described, the weak part of the plunger may include a plurality of tines. In this situation, when the plunger is returned to the extended position from the compressed position, the distal portion of the plunger may be disengaged from the weak portion by breaking the tines.
In a preferred embodiment, the safety syringe includes a plurality of o-rings formed on an outer surface of the stopper. The plurality of o-rings frictionally engage an inner surface of the syringe casing when the plunger is moved between the extended position and the compressed position.
In the safety-syringe above-described, the proximal end of the syringe casing comprises a cylindrical neck portion which houses the needle holder. The cylindrical neck portion comprises a circumferential channel formed on an inner surface thereof. The needle holder comprises a circumferential o-ring on an outer surface thereof which is sized to substantially fill the channel.
The safety-syringe may also include a safety mechanism. The safety mechanism comprises a check plate which is affixed to an outer surface of the syringe casing and which is adapted to move from an unlocked position to a locked position. The check plate is designed to engage a notch in a side of the distal portion of the plunger. When the check plate is in the locked position, it engages the notch thereby preventing the plunger from moving from the extended position to the compressed position.
In the presently described safety syringe, the needle and the syringe casing have longitudinal axes. Before engagement of the arrowhead and the coupling portion, the needle axis and the syringe casing axis are substantially parallel. By way of contrast, after the needle holder and the needle are drawn into the interior of the syringe casing, a mechanism alters the orientation of the needle axis with respect to the syringe axis so that they are not substantially parallel. Additionally, the proximal end of the syringe casing comprises a cylindrical neck portion which houses the needle holder; a circumferential wall extends from an interior end of the cylindrical neck portion to an outer surface of the proximal end of syringe casing. Due to the misalignment of the needle axis and the syringe casing axis, the needle will contact the wall if the plunger is moved toward the compressed position.
Ideally, the stopper substantially covers the coupling portion of the plunger when the plunger is in the extended position. Moreover, when the plunger is in the compressed position (i.e., after engagement of the arrowhead and the coupling portion housed within the stopper), the stopper substantially covers the arrowhead and the coupling portion.
A second embodiment of a safety syringe includes a syringe barrel and a needle holder, having an arrowhead at a rear portion thereof, sealingly installed onto a front end of the syringe barrel. The arrowhead has a circumferential groove disposed at its base. A needle is sleeved onto the needle holder. A cylindrical rubber stopper, coupled to a plunger, has a membrane at on one end and a bore at the other end. The plunger has an coupling portion dimensioned to engage the arrowhead. The rubber stopper is hollow and is sleeved over the plunger coupling portion. Moreover, the plunger is moveable between an extended position and an compressed position at which an injection is completed. The rubber stopper and the plunger are sequentially installed into the syringe barrel.
In the syringe of this type, the membrane end of the rubber stopper faces the arrowhead; at the completion of the injection, the arrowhead pierces the membrane and engages the coupling portion. After this engagement, when the plunger is drawn backwards towards the extended position, the needle holder and the needle are drawn into the syringe barrel.
Preferably, the syringe also includes an inner sealing channel on an internal side of the front end of the syringe barrel. Correspondingly, a sealing ring sleeved onto the needle holder is preferably dimensioned to match the inner sealing channel. A rear portion of the inner sealing channel should have a smaller arc than an arc of the sealing ring. Moreover, a frontal portion of the inner sealing channel should have an inclined face having an arc larger than the arc of the rear portion. In a syringe having these channel characteristics, the needle holder can be slideably engaged in the front end of the syringe barrel by means of the sealing ring and can be moved in the direction of the syringe barrel when the plunger is withdrawn are engagement of the arrowhead and coupling portion.
The plunger in a safety syringe of this nature preferably comprises a weak portion and a resistance plate fixedly connected to the coupling portion. Moreover, the plunger preferably has a “+” shaped formed by a vertical rib plate and a horizontal cross rib plate. The vertical rib plate is weakly connected to the resistance plate by means of a plurality of tines. After completion of the injection and after the needle holder and needle are drawn into the syringe barrel, the tines of the weak portion can be broken upon application of a bending moment.
Similar to the first embodiment, the safety syringe may also include a mechanism by which premature use of the syringe is prevented. Specifically, the syringe may include a safety mechanism having a wing plate, a check plate, and a flexible film connecting the wing plate and the check plate. The safety mechanism is positioned on an exterior surface of the syringe barrel at a position proximate to an insertion bore into which the plunger is inserted. The check plate and one rib of the vertical rib plate have corresponding grooves which may be engaged if the check plate is rotated toward the vertical rib plate by means of the flexible film. If the grooves of the check plate and the vertical rib plate are engaged, premature completion of the injection is prevented.
Ideally, a plane forming the base of the arrowhead is not perpendicular to a central axis of the syringe barrel. In this fashion, after the needle is drawn into the syringe barrel, the axis of the needle will be directed toward an inner wall of the syringe barrel; a subsequent re-compression of the plunger toward the compressed position will cause the needle to abut the inner wall of the syringe barrel.
The present invention also contemplates a method for preventing reuse of a syringe. The method uses a syringe having a syringe casing which, in turn, has a longitudinal axis, a distal end, and a proximal end having a cylindrical neck portion. In the syringe used by the method, a circumferential wall extends from an interior end of the cylindrical neck portion to an outer surface of the proximal end of syringe casing. A plunger having a weak portion, a distal portion, and a coupling portion, is channeled in the syringe casing and is moveable from an extended position to a compressed position. A stopper having a membrane is affixed to the coupling portion of the plunger; the membrane is between the proximal end of the syringe casing and the plunger. A needle holder, housed in the cylindrical neck portion of the syringe casing, has a distally facing arrowhead and a proximally facing needle having an axis and a needle tip.
The method includes: (I) moving the plunger from the extended position to the compressed position; (II) puncturing the membrane with the arrowhead when the plunger is in the compressed position; (III) coupling the arrowhead to the coupling portion; (IV) returning the plunger to the extended position and thereby drawing the needle holder and the needle into an interior of the syringe casing; and (V) preventing reuse of the needle by either (a) altering the orientation of the needle axis with respect to the syringe casing axis from an orientation in which the axes were substantially parallel to an orientation in which the needle tip will encounter the circumferential wall if the plunger is moved back toward the compressed position or (b) disengaging the distal portion of the plunger by breaking the weak part.
In the method in which the preventing reuse of the needle is preformed by altering the orientation of the needle axis with respect to the syringe casing, a further step is possible. This method may also include bending the needle when the needle tip encounters the circumferential wall when the plunger is subsequently moved toward the compressed position.
In addition, in the method in which the preventing reuse of the needle is performed by disengaging the distal portion of the plunger from the weak part, the disengagement may occur if the weak part of the plunger is comprised of a plurality of tines which are easily broken upon application of a bending moment applied to the plunger when the plunger is in the extended position.
BRIEF DESCRIPTION OF THE DRAWINGS
The accompanying figures, which are incorporated in and constitute a part of the specification, illustrate presently preferred embodiments of the invention. Together with the above general description and the following detailed description, the figures serve to explain the principles of the invention.
FIG. 1
is a cross sectional side view of a syringe showing the syringe prior to complete compression of the plunger and where a locking mechanism, in a locked position, prevents such compression;
FIG. 2
is a cross sectional side view of a syringe showing the needle drawn into the chamber after the syringe's one-time use;
FIG. 3
is a cross sectional side view of a syringe showing the needle destroyed where a user tried to reuse the syringe;
FIG. 4
is a cross sectional side view of a syringe showing how the plunger can be broken, after use, to prevent reuse of the syringe;
FIG. 5
is a perspective view of the needle holder;
FIG. 6
is a cross sectional side view of a syringe casing;
FIG. 7
is a side view of a plunger.
FIG. 8
is a side view of a weak part of a plunger at which the plunger may be broken after the syringe is used showing the needle end and the pushing end portions of the plunger attached at the weak part;
FIG. 9
is a side view of the weak part of the plunger of
FIG. 8
showing only the needle end portion attached to the weak part;
FIG. 10
is a cross-sectional view of a stopper into which the needle portion of the stopper is inserted;
FIG. 11
is a cross sectional side view showing the engagement of the plunger and the needle holder; and
FIG. 12
is a top end view of the syringe casing showing the locking mechanism and finger supports.
DETAILED DESCRIPTION
A preferred embodiment of a safety syringe
1
will be hereafter described with reference to the figures.
FIG. 1
shows a non-activated safety syringe
1
comprising a plunger
2
having a weak part
3
, a coupling portion
4
, and a distal portion
5
. The plunger sits within a syringe casing
24
. Attached to the coupling portion
4
of the plunger
2
is a stopper
11
. The area within the casing
24
between a needle holder
16
and the stopper
11
defines a fluid chamber
14
which contains a fluid to be administered to a patient.
FIG. 7
shows a side view of the plunger
2
whereas
FIG. 8
focuses on the weak part
3
of the plunger
2
. On either side of the weak part
3
are the coupling portion
4
and the distal portion
5
. The coupling portion
4
has a front resistance plate
42
. The resistance plate
42
has a transitional arc brim on its front face whereas its rear face is substantially flat. The outer diameter of the resistance plate
42
is equal to or slightly smaller than the inner diameter of the syringe casing
24
. Although the diameter of the resistance plate
42
can be 0.1 mm smaller than the inner diameter of the syringe casing
24
, it should be larger than the inner diameter of a resistance ring
37
(hereafter described) circumferentially formed on the inner surface of the syringe casing
24
(as shown in FIG.
6
). Preferably, the weak part
3
is comprised of a small number of tines
8
which are attached to and positioned between the front resistance plate
42
and the distal portion
5
. The tines
8
are designed to break easily when a bending moment is applied to the distal portion
5
when the plunger
2
is in a fully extended position. However, numerous other embodiments can be employed to create a breakable weak part
3
.
The coupling portion
4
contains a plurality of hooks
6
which are designed to engage an arrowhead
7
, as described below. The distal portion
5
, on the other hand, can have a variety of cross sections. To balance cost and effectiveness, a “+” shape is preferable for the distal portion
5
; if this configuration is used, it is preferable to have a flat plate
32
affixed to the end of the plunger
2
so that a user will have a broad flat surface on which to place a thumb when compressing the plunger
2
into the syringe casing
24
. If the “+” shape is employed to form the distal portion
5
, one plane of the distal portion
5
(i.e. a vertical rib plate
43
) may have tines
8
extend therefrom (and attach to the front resistance plate
43
) whereas the other plane of the “+” shaped distal portion
5
(i.e. a horizontal rib plate
44
) may have no such tines
8
. Moreover, if the “+” shape is employed, in one of the sides of the cross section, a notch
9
may be positioned. The notch
9
is designed to engage a safety mechanism
10
which is preferably attached to the syringe casing
24
, as described below.
As can be seen in
FIG. 10
, centrally positioned in one end of a stopper
11
is a bore
12
which leads to a cavity
45
. The bore
12
does not completely penetrate the stopper
11
. Rather, the other end of the stopper
11
comprises a membrane
13
, the function of which is hereafter described. However, the bore
12
is extended by a smaller diameter bore
41
which extends to an inner side of the membrane
13
. In construction, the coupling portion
4
of the plunger
2
is completely inserted into the bore
12
of the stopper
11
until it rests in the cavity
45
. Preferably, the stopper
11
is made of rubber or a rubber-like material which allows the stopper to prevent the fluid (to be administered to a patient) from escaping a fluid chamber
14
in the syringe
1
. In preventing the passage of such fluids, the stopper
11
has a plurality of o-rings
15
formed along its outer circumference which frictionally engage the inner surface of the fluid chamber
14
. The stopper
11
substantially covers the hooks
6
of the coupling portion
4
of the plunger
2
; the hooks
6
are positioned in the cavity
45
and are covered by the membrane
13
prior to an activation of the syringe described below.
FIG. 5
, which shows a perspective view of a needle holder
16
, depicts another o-ring
17
in a central portion of the needle holder
16
. The o-ring
17
of the needle holder
16
sits within a circumferential channel and prevents the fluid (to be administered to a patient) from escaping the syringe
1
through a bore
18
, described below, and also prevents accidental needle ejection when large compressive loads are applied to the plunger
2
. The o-ring
17
is designed to engage a circumferential channel
26
in the cylindrical neck portion
25
of the syringe casing
24
, (as shown in
FIG. 2
) as hereafter described.
On one side of the o-ring
17
is a needle adapter
19
onto which a needle
20
is fixed. The needle adapter
19
is conical in shape which allows needles of various sizes to be fixed on the needle holder
16
. On the other side of the o-ring
17
is an arrowhead
7
. On one end of the arrowhead is a point
29
. At the base of the arrowhead
7
is a circumferential groove
28
designed to engage the hooks
6
of the plunger
2
, as described below. The base of the arrowhead
7
is made to be inclined, i.e. the angle of the base is at an angle a with respect to a coplanar line which is perpendicular to the axis of the syringe casing
24
; the angle is preferably approximately 5 degrees. This angular orientation allows the needle holder
16
to be oriented at an angle when it is withdrawn into the syringe casing
24
, as described below.
At the base of the groove
28
there are two flaps
40
which are designed to engage the wall
31
(as shown in
FIG. 2
) in the cylindrical neck
25
when the needle holder
16
is positioned in the cylindrical neck
25
. By engaging the wall
31
, the flaps
40
prevent the needle holder
16
from being ejected when the plunger
2
is compressed. Moreover, the engagement of the flaps
40
and the wall
31
reduces injection residue.
A needle holder axis
23
is defined by a line passing through the arrowhead
7
in the direction of the needle adapter
19
. Positioned in the needle adapter
19
of the needle holder
16
is a bore
22
which travels from the needle adapter end of the needle holder
16
along the axis
23
to a position on needle holder
16
which is on the arrowhead
7
side of the o-ring
17
; the bore
22
does not extend into the arrowhead
7
. A trans-bore
21
is perpendicularly drilled through the needle holder
16
at the end of the bore
22
, i.e. perpendicular to the axis
23
of the needle holder
16
. The two bores
21
and
22
thereby form a “T” shaped channel in the needle holder
16
. When a needle
20
is attached to the needle adapter
19
the “T” shaped channel extends into the needle. This construction allows a fluid, housed within the fluid chamber
14
, to pass through the “T” shaped channel (when the plunger
2
is depressed), through the needle
20
, and into a patient.
FIG. 6
shows a cross sectional side view of the syringe casing
24
. The casing
24
is substantially cylindrical and hollow. On one end of the casing
24
, there is a narrower cylinder
25
which extends from the casing
24
. Prior to use, the cylinder
25
(which comprises bore
18
) holds the needle holder
16
with the arrowhead
7
distally extending into the fluid chamber
14
. In the cylinder
25
, there is a circumferential channel
26
on the inner surface of the cylinder
25
. O-ring
17
of the needle holder
16
initially rests within channel
26
and thereby prevents drugs, stored in the fluid chamber
14
, from being able to leak out of the syringe
1
. The circumferential channel
26
has an asymmetric cross-section; the rear portion
38
has the same arc as the o-ring
17
whereas the frontal portion
39
(i.e. the portion closest to the needle end of the syringe
1
) has a larger arc.
Attached to the other end of the casing
24
are two finger supports
33
(as shown in
FIG. 12
) and the safety mechanism
10
. Safety mechanism
10
is formed onto the casing in such a way as to allow it to swing toward and away from the plunger
2
when the plunger
2
is positioned within the casing
24
. To allow the safety mechanism
10
to swing, the safety mechanism is comprised of a wing plate
34
(which is a part of the finger support
33
) which is connected to a check plate
35
by means of a thin plastic film
36
. Preferably, the check plate
35
has a notch
27
(as shown in
FIG. 12
) which is sized to correspond to the thickness of one of the sides of the “+” shaped plunger. When the check plate
35
is rotated from an unlocked position and toward the plunger
2
and thereby into a locked position, the notch
27
of the check plate
35
may engage the notch
9
in one of the sides of the “+” shaped plunger
2
. A user will be unable to activate (as described below) the syringe
1
by depressing the plunger
2
while the notch
27
is engaged with notch
9
as this engagement prevents further compression of the plunger
2
; accordingly, completely activation of the syringe
1
is avoided.
In addition, the rear end of the syringe casing
24
also comprises a resistance ring
37
formed on the interior of the casing
24
near the end of the casing
24
in which the plunger is inserted. The resistance ring
37
has a cross-section substantially triangular in shape. The cross-section of the ring
37
is such that the portion
47
of the cross-section facing the needle end of the syringe
1
is steeper than the portion
48
facing the plunger
2
end of the syringe
1
. In this fashion, the portion
47
of the ring
37
facing the needle
20
end of the syringe
1
has a larger axial angle with respect to the axis of the syringe casing
24
; the angle is preferably about 60 degrees. The side of the ring
37
facing the plunger
2
end of the syringe
1
has a smaller axial angle with respect to the axis of the syringe casing
24
; the angle is preferably about 10 degrees.
During assembly, the needle holder
16
is channeled into the syringe casing
24
through the plunger
2
end of the casing
24
. The needle holder
16
is then pushed forward until the o-ring
17
snaps into the circumferential channel
26
and the flaps
40
hit a circumferential rim
46
located in the cylindrical neck portion
25
adjacent the circumferential wall
31
. The hooks
6
of the plunger
2
are inserted into the bore
12
in the stopper
11
until the are housed in the cavity
45
; the combination of the plunger
2
and the stopper
11
is then inserted into the syringe casing
24
. In so doing, the front resistance plate
42
of the plunger
2
rides over the resistance ring
37
to become permanently housed with the syringe casing
24
. The check plate
35
of the safety mechanism
10
should be turned down toward the plunger
2
(i.e. into the locked position) by means of the bendable film plastic film
36
and its notch
27
should be aligned with the side of the “+” shaped plunger containing the corresponding notch
9
so that an engagement of the notches
9
,
27
can occur thereby preventing complete compression of the plunger
2
in the syringe casing
24
.
Activation of the syringe
1
occurs as follows. When the safety mechanism
10
is not engaged with one of the sides of the plunger
2
and a user depresses the plunger
2
to compress the fluid chamber
14
, drugs in the fluid chamber are forced into the “T” shaped channel of the needle holder
16
and into (and out of) the needle
20
. As the plunger is compressed, the membrane
13
of the stopper
11
approaches the arrowhead
7
. With continued compression, the point
29
of the arrowhead
7
pierces the membrane
13
causing the arrowhead
7
to pass through bore
41
and into cavity
45
in which the arrowhead
7
engages the hooks
6
. Again, with continued compression, the arrowhead
7
radially separates the hooks
6
to a point at which the hooks
6
snap into the circumferential groove
28
around the base of the arrowhead
7
as shown in FIG.
11
. In this fashion the arrowhead
7
and the plunger
2
become permanently engaged within the stopper
11
. Due to the engagement of the hooks
6
with the circumferential groove
28
, when a user pulls on the plunger
2
, the needle holder
16
(to which the arrowhead
7
is attached) and the needle
20
are pulled into the syringe casing
24
. The user is unable to pull the plunger (with needle attached) out of the syringe casing
24
because front resistance plate
42
of the plunger
2
engages the frontal portion
47
of the resistance ring
37
.
As shown in
FIG. 4
, when the needle
20
is completely pulled into the syringe casing
24
, the distal portion
5
of the plunger
2
extends well out of the casing
24
. With a small bending moment applied to a side of the distal portion
5
, the tines
8
of the weak point
3
break. As shown in
FIGS. 4 and 9
, when the tines
8
break, the distal portion
5
of the plunger
2
becomes disengaged from the coupling portion
4
of the plunger
2
. Without the distal portion
5
attached to the coupling portion
4
of the plunger
2
, a user is unable to push the needle
20
back out of the casing
24
. If, on the other hand, the user does not break the distal portion
5
and instead tries to push the needle
20
out of the casing
24
, the user will be unable to push the needle
20
out of the casing
24
for the reason discussed below.
As shown in
FIG. 2
, when the needle holder
16
is drawn into the casing
24
(after complete activation) and the skin contact end
30
of the needle
20
clears the bore
18
of the cylinder
25
, the skin contact end
30
of the needle
20
is forced toward the inner surface of the casing
24
. The needle
20
is tipped toward the inner surface of the casing
24
because the arrowhead
7
and hooks
6
are engaged at an angle of approximately 5 degrees; the angular orientation is caused by the inclined base of the arrowhead
7
as previously described. In this fashion, the axis defined by the needle
20
(when completely within the casing
24
) is not parallel to the axis upon which the plunger
2
is pulled by the user. As shown in
FIG. 3
, if a user tries to push the needle
20
back out of the casing
24
, the skin contact end
30
of the needle
20
does not pass through bore
18
but rather contacts a wall
31
of the casing which extends circumferentially from the outer surface of the casing
24
toward the cylinder
25
. Due to the contact between the skin contact end
30
of the needle
20
and the wall
31
, the needle is unable to exit the casing
24
. Moreover, if the user continuously increases the force applied to the plunger
2
, the needle will collapse.
Although the aforementioned described a preferred embodiment of the invention, the invention is not so restricted. The foregoing description is for exemplary purposes only and is not intended to be limiting. Accordingly, alternatives which would be obvious to one of ordinary skill in the art upon reading the teachings herein disclosed, are hereby within the scope of this invention. The invention is limited only as defined in the following claims and equivalents thereof.
Claims
- 1. A safety syringe comprising:a syringe barrel; a needle holder sealingly installed onto a front end of the syringe barrel, the needle holder having an arrowhead at a rear portion thereof; a needle sleeved onto the needle holder; a plunger having an coupling portion dimensioned to engage the arrowhead, the plunger moveable between an extended position and an compressed position at which an injection is completed; and a cylindrical rubber stopper, having a membrane at one end and a bore at the other end, is coupled to the plunger; wherein the rubber stopper and the plunger are sequentially installed into the syringe barrel, wherein the arrowhead has a circumferential groove disposed at a base of the arrowhead, wherein the rubber stopper is hollow and sleeved over the coupling portion, wherein the membrane end of the rubber stopper faces the arrowhead, wherein at the completion of the injection, the arrowhead pierces the membrane and engages the coupling portion, and wherein when the plunger is drawn backwards towards the extended position after the engagement of the arrowhead and the plunger coupling portion, the needle holder and the needle are drawn into the syringe barrel.
- 2. The syringe according to claim 1, further comprising:an inner sealing channel on an internal side of the front end of the syringe barrel; and a sealing ring sleeved onto the needle holder and dimensioned to match the inner sealing channel, wherein a rear portion of the inner sealing channel has a smaller arc than an arc of the sealing ring, wherein a frontal portion of the inner sealing channel has an inclined face having an arc larger than the arc of the rear portion, wherein the needle holder is slideably engaged in the front end of the syringe barrel by means of the sealing ring, and wherein the needle holder can move in the direction of the syringe barrel when the plunger is withdrawn after engagement of the arrowhead and coupling portion.
- 3. The syringe according to claim 1, wherein a plane forming the base of the arrowhead is not perpendicular to a central axis of the syringe barrel, wherein after the needle is drawn into the syringe barrel, an axis of the needle is directed toward an inner wall of the syringe barrel, and wherein a subsequent re-compression of the plunger toward the compressed position causes the needle to abut the inner wall of the syringe barrel.
- 4. The syringe according to claim 1, wherein said plunger comprises a weak portion and a resistance plate fixedly connected to the coupling portion, wherein said plunger has a “+” shape comprised of a vertical rib plate and a horizontal cross rib plate, wherein the vertical rib plate is weakly connected to the resistance plate by means of a plurality of tines, and wherein after completion of the injection and after the needle holder and needle are drawn into the syringe barrel, the weak portion can be broken upon application of a bending moment.
- 5. The syringe according to claim 4, further comprising:a safety mechanism having a wing plate, a check plate, and a flexible film connecting the wing plate and the check plate, wherein the safety mechanism is positioned on an exterior surface of the syringe barrel at a position proximate to an insertion bore into which the plunger is inserted, wherein one rib of said vertical rib plate has a groove, wherein the check plate has a groove, wherein the groove of the check plate and the groove of the vertical rib plate may be engaged if the check plate is rotated toward the vertical rib plate by means of the flexible film, and wherein if the groove of the check plate and the groove of the vertical rib plate are engaged, premature completion of the injection is prevented.
- 6. A safety syringe comprising:a syringe casing having a distal end and a proximal end; a plunger channeled in the syringe casing and moveable from an extended position to a compressed position, wherein the plunger has a weak portion, a distal portion, and a coupling portion comprising a plurality of hooks; a stopper having a membrane, wherein the stopper is affixed to the coupling portion of the plunger, and wherein the membrane is between the proximal end of the syringe casing and the plunger; a needle holder initially coupled to the proximal end of the syringe casing; a distally facing arrowhead attached to a distal end of the needle holder; a proximally facing needle attached to a proximal end of the needle holder, wherein when the plunger is moved from the extended position to the compressed position, the arrowhead punctures the membrane and lockingly engages each of the hooks of the coupling portion of the plunger, and wherein when the plunger is returned to the extended position after engagement of the arrowhead and coupling portion, the needle holder and needle are drawn into an interior of the syringe casing.
- 7. The syringe according to claim 6, further comprising:a plurality of o-rings formed on an outer surface of the stopper, wherein the plurality of o-rings frictionally engage an inner surface of the syringe casing when the plunger is moved between the extended position and the compressed position.
- 8. The syringe according to claim 6, wherein the proximal end of the syringe casing comprises a cylindrical neck portion which houses the needle holder.
- 9. The syringe according to claim 6, wherein the weak part of the plunger includes a plurality of tines.
- 10. The syringe according to claim 9, wherein when the plunger is returned to the extended position from the compressed position, the distal portion of the plunger may be disengaged from the weak portion by breaking the tines.
- 11. A safety syringe comprising:a syringe casing having a distal end and a proximal end; a plunger channeled in the syringe casing and moveable from an extended position to a compressed position, wherein the plunger has a weak portion, a distal portion, and a coupling portion; a stopper having a membrane, wherein the stopper is affixed to the coupling portion of the plunger, and wherein the membrane is between the proximal end of the syringe casing and the plunger; a needle holder initially coupled to the proximal end of the syringe casing; a distally facing arrowhead attached to a distal end of the needle holder; and a proximally facing needle attached to a proximal end of the needle holder, wherein when the plunger is moved from the extended position to the compressed position, the arrowhead punctures the membrane and lockingly engages the coupling portion of the plunger, wherein when the plunger is returned to the extended position after engagement of the arrowhead and coupling portion, the needle holder and needle are drawn into an interior of the syringe casing, wherein the proximal end of the syringe casing comprises a cylindrical neck portion which houses the needle holder, wherein the cylindrical neck portion comprises a circumferential channel formed on an inner surface thereof, and wherein the needle holder comprises a circumferential o-ring on an outer surface thereof which is sized to substantially fill the channel.
- 12. The syringe according to claim 11, further comprising:a plurality of o-rings formed on an outer surface of the stopper, wherein the plurality of o-rings formed on the outer surface of the stopper frictionally engage an inner surface of the syringe casing when the plunger is moved between the extended position and the compressed position.
- 13. The syringe according to claim 11, wherein the stopper substantially covers the coupling portion of the plunger when the plunger is in the extended position, and wherein the stopper substantially covers the arrowhead and the coupling portion when the plunger is in the compressed position.
- 14. The syringe according to claim 11, wherein the needle has a longitudinal axis, wherein the syringe casing has a longitudinal axis, wherein before engagement of the arrowhead and the coupling portion, the needle axis and the syringe casing axis are substantially parallel, and wherein after engagement of the arrowhead and the coupling portion and after the needle holder and the needle are drawn into the interior of the syringe casing, a mechanism alters the orientation of the needle axis with respect to the syringe axis so that they are not substantially parallel.
- 15. The syringe according to claim 14, wherein the proximal end of the syringe casing comprises a cylindrical neck portion which houses the needle holder, wherein a circumferential wall extends from an interior end of the cylindrical neck portion to an outer surface of the proximal end of syringe casing, and wherein the needle will contact the wall if the plunger is moved toward the compressed position.
- 16. A safety syringe comprising:a syringe casing having a distal end and a proximal end; a plunger channeled in the syringe casing and moveable from an extended position to a compressed position, wherein the plunger has a weak portion, a distal portion, and a coupling portion; a stopper having a membrane, wherein the stopper is affixed to the coupling portion of the plunger, and wherein the membrane is between the proximal end of the syringe casing and the plunger; a needle holder initially coupled to the proximal end of the syringe casing; a distally facing arrowhead attached to a distal end of the needle holder; a proximally facing needle attached to a proximal end of the needle holder; a safety mechanism comprising a check plate affixed to an outer surface of the syringe casing, the check plate adapted to move from an unlocked position to a locked position; and a notch in a side of the distal portion of the plunger, wherein when the plunger is moved from the extended position to the compressed position, the arrowhead punctures the membrane and lockingly engages the coupling portion of the plunger, wherein when the plunger is returned to the extended position after engagement of the arrowhead and coupling portion, the needle holder and needle are drawn into an interior of the syringe casing, and wherein when the check plate is in the locked position, it engages the notch thereby preventing the plunger from moving from the extended position to the compressed position.
- 17. A method of preventing reuse of a syringe including a syringe casing having a longitudinal axis, a distal end, and a proximal end having a cylindrical neck portion, a circumferential wall extending from an interior end of the cylindrical neck portion to an outer surface of the proximal end of syringe casing; a plunger having a weak portion, a distal portion, and a coupling portion comprising a plurality of hooks, wherein the plunger is channeled in the syringe casing and is moveable from an extended position to a compressed position; a stopper having a membrane, wherein the stopper is affixed to the coupling portion of the plunger, and wherein the membrane is between the proximal end of the syringe casing and the plunger; a needle holder housed in the cylindrical neck portion of the syringe casing; a distally facing arrowhead attached to a distal end of the needle holder; a proximally facing needle attached to a proximal end of the needle holder and having a needle axis and a needle tip, the method comprising the steps of:moving the plunger from the extended position to the compressed position; puncturing the membrane with the arrowhead when the plunger is in the compressed position; coupling the arrowhead to each of the hooks of the coupling portion; returning the plunger to the extended position and thereby drawing the needle holder and the needle into an interior of the syringe casing; and preventing needle reuse by performing a step selected from the group consisting of: altering the orientation of the needle axis with respect to the syringe casing axis from an orientation in which the axes are substantially parallel to an orientation in which the needle tip will encounter the circumferential wall if the plunger is moved back toward the compressed position; and disengaging the distal portion of the plunger from the weak part.
- 18. The method according to claim 17, further comprising the step of:bending the needle when the needle tip encounters the circumferential wall and when the plunger is moved toward the compressed position after the step of altering the orientation of the needle axis with respect to the syringe casing axis.
- 19. The method according to claim 17, wherein the weak part of the plunger includes a plurality of tines, and wherein the step of disengaging the distal portion of the plunger from the weak part comprises breaking the tines.
Priority Claims (1)
Number |
Date |
Country |
Kind |
0020587 U |
Feb 2000 |
CN |
|
US Referenced Citations (444)
Number |
Name |
Date |
Kind |
187031 |
McMorries |
Feb 1877 |
A |
2617359 |
Van Horn et al. |
Nov 1952 |
A |
2722215 |
Dahlgren |
Nov 1955 |
A |
2880723 |
Adams |
Apr 1959 |
A |
3306290 |
Weltman |
Feb 1967 |
A |
3426448 |
Sarnoff |
Feb 1969 |
A |
3848593 |
Baldwin |
Nov 1974 |
A |
3889673 |
Dovey et al. |
Jun 1975 |
A |
3890971 |
Leeson et al. |
Jun 1975 |
A |
4026287 |
Haller |
May 1977 |
A |
4034755 |
Schultz |
Jul 1977 |
A |
4356822 |
Winstead-Hall |
Nov 1982 |
A |
4425120 |
Sampson et al. |
Jan 1984 |
A |
4507117 |
Vining et al. |
Mar 1985 |
A |
4643199 |
Jennings, Jr. et al. |
Feb 1987 |
A |
4643200 |
Jennings, Jr. |
Feb 1987 |
A |
4664654 |
Strauss |
May 1987 |
A |
4666435 |
Braginetz |
May 1987 |
A |
4675005 |
DeLuccia |
Jun 1987 |
A |
4692156 |
Haller |
Sep 1987 |
A |
4710170 |
Haber et al. |
Dec 1987 |
A |
4747830 |
Gloyer et al. |
May 1988 |
A |
4790822 |
Haining |
Dec 1988 |
A |
4804370 |
Haber et al. |
Feb 1989 |
A |
4826484 |
Haber et al. |
May 1989 |
A |
4838870 |
Haber et al. |
Jun 1989 |
A |
4887999 |
Alles |
Dec 1989 |
A |
4892107 |
Haber |
Jan 1990 |
A |
4894055 |
Sudnak |
Jan 1990 |
A |
4898589 |
Dolgin et al. |
Feb 1990 |
A |
4900304 |
Fujioka et al. |
Feb 1990 |
A |
4900307 |
Kulli |
Feb 1990 |
A |
4904242 |
Kulli |
Feb 1990 |
A |
4906231 |
Young |
Mar 1990 |
A |
4908020 |
Pettersen |
Mar 1990 |
A |
4908022 |
Haber |
Mar 1990 |
A |
4908023 |
Yuen |
Mar 1990 |
A |
4909794 |
Haber et al. |
Mar 1990 |
A |
4909795 |
Gelabert |
Mar 1990 |
A |
4915692 |
Verlier |
Apr 1990 |
A |
4915700 |
Noonan, Jr. |
Apr 1990 |
A |
4919652 |
Alter et al. |
Apr 1990 |
A |
4921486 |
DeChellis et al. |
May 1990 |
A |
4923443 |
Greenwood et al. |
May 1990 |
A |
4927414 |
Kulli |
May 1990 |
A |
4929231 |
Pawlikowski |
May 1990 |
A |
4931040 |
Haber et al. |
Jun 1990 |
A |
4932939 |
Magre et al. |
Jun 1990 |
A |
4932940 |
Walker et al. |
Jun 1990 |
A |
4932941 |
Min et al. |
Jun 1990 |
A |
4935014 |
Haber |
Jun 1990 |
A |
4936830 |
Verlier |
Jun 1990 |
A |
4941879 |
Butler et al. |
Jul 1990 |
A |
4941883 |
Venturini |
Jul 1990 |
A |
4944723 |
Haber et al. |
Jul 1990 |
A |
4947863 |
Haber et al. |
Aug 1990 |
A |
4950240 |
Greenwood et al. |
Aug 1990 |
A |
4950241 |
Ranford |
Aug 1990 |
A |
4950243 |
Estruch |
Aug 1990 |
A |
4950251 |
Haining |
Aug 1990 |
A |
4952206 |
Ibanez et al. |
Aug 1990 |
A |
4955869 |
Bin |
Sep 1990 |
A |
4955870 |
Ridderheim et al. |
Sep 1990 |
A |
4957490 |
Byrne et al. |
Sep 1990 |
A |
4961728 |
Kosinski |
Oct 1990 |
A |
4966593 |
Lennox |
Oct 1990 |
A |
4973308 |
Borras et al. |
Nov 1990 |
A |
4973309 |
Sultan |
Nov 1990 |
A |
4973310 |
Kosinski |
Nov 1990 |
A |
4973316 |
Dysarz |
Nov 1990 |
A |
4976925 |
Porcher et al. |
Dec 1990 |
A |
4978339 |
Labouze et al. |
Dec 1990 |
A |
4978340 |
Terrill et al. |
Dec 1990 |
A |
4978343 |
Dysarz et al. |
Dec 1990 |
A |
4979943 |
Trenner |
Dec 1990 |
A |
4985021 |
Straw et al. |
Jan 1991 |
A |
4986812 |
Perler |
Jan 1991 |
A |
4986813 |
Blake, III et al. |
Jan 1991 |
A |
4989589 |
Pekanmäki et al. |
Feb 1991 |
A |
4994034 |
Botich et al. |
Feb 1991 |
A |
4995869 |
McCarthy |
Feb 1991 |
A |
4995870 |
Baskas |
Feb 1991 |
A |
4995874 |
Strickland |
Feb 1991 |
A |
4998924 |
Ranford |
Mar 1991 |
A |
5000735 |
Whelan |
Mar 1991 |
A |
5000736 |
Kaufhold, Jr. et al. |
Mar 1991 |
A |
5000737 |
Free et al. |
Mar 1991 |
A |
5004460 |
Gimeno |
Apr 1991 |
A |
5007903 |
Ellard |
Apr 1991 |
A |
5011476 |
Foster |
Apr 1991 |
A |
5013301 |
Marotta, Jr. et al. |
May 1991 |
A |
5017187 |
Sullivan |
May 1991 |
A |
5019043 |
Segui Pastor et al. |
May 1991 |
A |
5019044 |
Tsao |
May 1991 |
A |
5019045 |
Lee |
May 1991 |
A |
5019046 |
Kohler |
May 1991 |
A |
5024661 |
Wender et al. |
Jun 1991 |
A |
5026346 |
Spanner et al. |
Jun 1991 |
A |
5026354 |
Kocses |
Jun 1991 |
A |
5030208 |
Novacek et al. |
Jul 1991 |
A |
5032114 |
Olovson |
Jul 1991 |
A |
5034002 |
Duränzampa et al. |
Jul 1991 |
A |
5037393 |
Ellgass |
Aug 1991 |
A |
5037394 |
Mazurik et al. |
Aug 1991 |
A |
5045063 |
Spielberg |
Sep 1991 |
A |
5047016 |
Dolgin et al. |
Sep 1991 |
A |
5047017 |
Koska |
Sep 1991 |
A |
5049133 |
Vittan Pascual |
Sep 1991 |
A |
5053010 |
McGary et al. |
Oct 1991 |
A |
5059179 |
Quatrochi et al. |
Oct 1991 |
A |
5059180 |
McLees |
Oct 1991 |
A |
5059181 |
Agran |
Oct 1991 |
A |
5061249 |
Campbell |
Oct 1991 |
A |
5062833 |
Perler |
Nov 1991 |
A |
5064419 |
Gaarde |
Nov 1991 |
A |
5066277 |
Carrell et al. |
Nov 1991 |
A |
5066280 |
Braithwaite |
Nov 1991 |
A |
5066281 |
Stevenson-Michener |
Nov 1991 |
A |
5067490 |
Haber |
Nov 1991 |
A |
5067942 |
Jaffe et al. |
Nov 1991 |
A |
5078686 |
Bates |
Jan 1992 |
A |
5084017 |
Maffetone |
Jan 1992 |
A |
5084018 |
Tsao |
Jan 1992 |
A |
5084019 |
Gartz |
Jan 1992 |
A |
5084020 |
Gartz |
Jan 1992 |
A |
5085638 |
Farbstein et al. |
Feb 1992 |
A |
5085640 |
Gibbs |
Feb 1992 |
A |
5088987 |
Noonan, Jr. |
Feb 1992 |
A |
5090961 |
Maruzik et al. |
Feb 1992 |
A |
5090962 |
Landry, Jr. et al. |
Feb 1992 |
A |
5092853 |
Couvertier, II |
Mar 1992 |
A |
5098382 |
Haber et al. |
Mar 1992 |
A |
5098390 |
Wallingford |
Mar 1992 |
A |
5098402 |
Davis |
Mar 1992 |
A |
5104378 |
Haber et al. |
Apr 1992 |
A |
5106371 |
Zhao et al. |
Apr 1992 |
A |
5106372 |
Ranford |
Apr 1992 |
A |
5112118 |
Wiehle |
May 1992 |
A |
5112316 |
Venturini |
May 1992 |
A |
5114404 |
Paxton et al. |
May 1992 |
A |
5114405 |
Winter |
May 1992 |
A |
5114410 |
Caralt Batlle |
May 1992 |
A |
5116319 |
van den Haak |
May 1992 |
A |
5116320 |
Lo Duca |
May 1992 |
A |
5120309 |
Watts |
Jun 1992 |
A |
5120310 |
Shaw |
Jun 1992 |
A |
5120311 |
Sagstetter et al. |
Jun 1992 |
A |
5120314 |
Greenwood |
Jun 1992 |
A |
5122118 |
Haber et al. |
Jun 1992 |
A |
5122124 |
Novacek et al. |
Jun 1992 |
A |
5125898 |
Kaufhold, Jr. et al. |
Jun 1992 |
A |
5125899 |
Frignoli |
Jun 1992 |
A |
5125908 |
Cohen |
Jun 1992 |
A |
5127906 |
Landry, Jr. et al. |
Jul 1992 |
A |
5135495 |
Arcusin |
Aug 1992 |
A |
5147303 |
Martin |
Sep 1992 |
A |
5149323 |
Colonna |
Sep 1992 |
A |
5152750 |
Haining |
Oct 1992 |
A |
5152752 |
Hammami |
Oct 1992 |
A |
5152753 |
Hammami |
Oct 1992 |
A |
5158549 |
McCarthy |
Oct 1992 |
A |
5158550 |
Scholl, Jr. |
Oct 1992 |
A |
5163907 |
Szuszkiewicz |
Nov 1992 |
A |
5163916 |
Sunderland |
Nov 1992 |
A |
5163918 |
Righi et al. |
Nov 1992 |
A |
5167641 |
Schmitz |
Dec 1992 |
A |
5171300 |
Blake, III et al. |
Dec 1992 |
A |
5176639 |
Pozzi et al. |
Jan 1993 |
A |
5176640 |
Nacci et al. |
Jan 1993 |
A |
5180369 |
Dysarz |
Jan 1993 |
A |
5180370 |
Gillespie |
Jan 1993 |
A |
5181912 |
Hammett |
Jan 1993 |
A |
5183466 |
Movern |
Feb 1993 |
A |
5188597 |
Sweeney et al. |
Feb 1993 |
A |
5188599 |
Botich et al. |
Feb 1993 |
A |
5188601 |
King |
Feb 1993 |
A |
5188614 |
Hart |
Feb 1993 |
A |
5190526 |
Murray et al. |
Mar 1993 |
A |
5195973 |
Novick |
Mar 1993 |
A |
5195975 |
Castagna |
Mar 1993 |
A |
5195985 |
Hall |
Mar 1993 |
A |
5201708 |
Martin |
Apr 1993 |
A |
5201709 |
Capra et al. |
Apr 1993 |
A |
5201710 |
Caselli |
Apr 1993 |
A |
5201719 |
Collins et al. |
Apr 1993 |
A |
5205823 |
Zdeb |
Apr 1993 |
A |
5205824 |
Mazur |
Apr 1993 |
A |
5205825 |
Allison et al. |
Apr 1993 |
A |
5205826 |
Chen |
Apr 1993 |
A |
5205827 |
Novacek et al. |
Apr 1993 |
A |
5207646 |
Brunel |
May 1993 |
A |
5211628 |
Marshall |
May 1993 |
A |
5211629 |
Pressly et al. |
May 1993 |
A |
5211630 |
Schmahmann |
May 1993 |
A |
5215524 |
Vallelunga et al. |
Jun 1993 |
A |
5215533 |
Robb |
Jun 1993 |
A |
5215534 |
De Harde et al. |
Jun 1993 |
A |
5219333 |
Sagstetter et al. |
Jun 1993 |
A |
5221262 |
Kite |
Jun 1993 |
A |
5222942 |
Bader |
Jun 1993 |
A |
5222943 |
Mazzara |
Jun 1993 |
A |
5222944 |
Harris |
Jun 1993 |
A |
5222945 |
Basnight |
Jun 1993 |
A |
5226881 |
Pickhard |
Jul 1993 |
A |
5226882 |
Bates |
Jul 1993 |
A |
5226884 |
Murphy |
Jul 1993 |
A |
5226893 |
Kayser |
Jul 1993 |
A |
5232447 |
Schwarz et al. |
Aug 1993 |
A |
5232458 |
Chen |
Aug 1993 |
A |
5242400 |
Blake, III et al. |
Sep 1993 |
A |
5242402 |
Chen |
Sep 1993 |
A |
5250030 |
Corsich |
Oct 1993 |
A |
5254093 |
Bartlett et al. |
Oct 1993 |
A |
5256151 |
Chul |
Oct 1993 |
A |
5257976 |
Fenet |
Nov 1993 |
A |
5259840 |
Boris |
Nov 1993 |
A |
5259841 |
Hohendorf et al. |
Nov 1993 |
A |
5261880 |
Streck et al. |
Nov 1993 |
A |
5263933 |
Novacek et al. |
Nov 1993 |
A |
5263934 |
Haak |
Nov 1993 |
A |
5263942 |
Smedley et al. |
Nov 1993 |
A |
5267961 |
Shaw |
Dec 1993 |
A |
5267962 |
Jenson |
Dec 1993 |
A |
5267973 |
Haber et al. |
Dec 1993 |
A |
5269760 |
Bina |
Dec 1993 |
A |
5269761 |
Stehrenberger et al. |
Dec 1993 |
A |
5273538 |
Chen |
Dec 1993 |
A |
5273539 |
Chen |
Dec 1993 |
A |
5273540 |
Luther et al. |
Dec 1993 |
A |
5273541 |
Malenchek |
Dec 1993 |
A |
5273543 |
Bell et al. |
Dec 1993 |
A |
5279566 |
Kline, Jr. et al. |
Jan 1994 |
A |
5290233 |
Campbell |
Mar 1994 |
A |
5290235 |
Polyblank et al. |
Mar 1994 |
A |
5295973 |
Chen |
Mar 1994 |
A |
5304137 |
Fluke |
Apr 1994 |
A |
5304138 |
Mercado |
Apr 1994 |
A |
5304150 |
Duplan et al. |
Apr 1994 |
A |
5306258 |
de la Fuente |
Apr 1994 |
A |
5308329 |
Mazur et al. |
May 1994 |
A |
5308331 |
Avila et al. |
May 1994 |
A |
5312348 |
Sans |
May 1994 |
A |
5312372 |
DeHarde et al. |
May 1994 |
A |
5318536 |
Williams |
Jun 1994 |
A |
5318537 |
Van Der Merwe |
Jun 1994 |
A |
5318538 |
Martin |
Jun 1994 |
A |
5320606 |
Jore |
Jun 1994 |
A |
5324265 |
Murray et al. |
Jun 1994 |
A |
5328473 |
Fayngold et al. |
Jul 1994 |
A |
5328475 |
Chen |
Jul 1994 |
A |
5328476 |
Bidwell |
Jul 1994 |
A |
5328484 |
Somers et al. |
Jul 1994 |
A |
5330440 |
Stanners et al. |
Jul 1994 |
A |
5334149 |
Nortman et al. |
Aug 1994 |
A |
5334155 |
Sobel |
Aug 1994 |
A |
5334156 |
Servano Gonzalez |
Aug 1994 |
A |
5334158 |
McLees |
Aug 1994 |
A |
5336185 |
Lynch et al. |
Aug 1994 |
A |
5336186 |
Haber et al. |
Aug 1994 |
A |
5336187 |
Terry et al. |
Aug 1994 |
A |
5336198 |
Silver et al. |
Aug 1994 |
A |
5338303 |
King et al. |
Aug 1994 |
A |
5338304 |
Adams |
Aug 1994 |
A |
5338310 |
Lewandowski |
Aug 1994 |
A |
5338311 |
Mahurkar |
Aug 1994 |
A |
5342308 |
Boschetti |
Aug 1994 |
A |
5342309 |
Hausser |
Aug 1994 |
A |
5342310 |
Ueyama et al. |
Aug 1994 |
A |
5342323 |
Haining |
Aug 1994 |
A |
5344403 |
Lee |
Sep 1994 |
A |
5344405 |
Richards |
Sep 1994 |
A |
5346474 |
King |
Sep 1994 |
A |
5346475 |
Gregorio |
Sep 1994 |
A |
5352200 |
Hammett et al. |
Oct 1994 |
A |
5352202 |
Hammett et al. |
Oct 1994 |
A |
5352203 |
Vallelunga et al. |
Oct 1994 |
A |
5360404 |
Novacek et al. |
Nov 1994 |
A |
5360410 |
Wacks |
Nov 1994 |
A |
5364359 |
van den Haak |
Nov 1994 |
A |
5364360 |
Flumene et al. |
Nov 1994 |
A |
5368568 |
Pitts et al. |
Nov 1994 |
A |
5370619 |
Rossi |
Dec 1994 |
A |
5370620 |
Shonfeld |
Dec 1994 |
A |
5370654 |
Abidin et al. |
Dec 1994 |
A |
5372590 |
Haber et al. |
Dec 1994 |
A |
5374250 |
Dixon |
Dec 1994 |
A |
5376000 |
Petrussa |
Dec 1994 |
A |
5376080 |
Petrussa |
Dec 1994 |
A |
5378240 |
Curie et al. |
Jan 1995 |
A |
5395346 |
Maggioni |
Mar 1995 |
A |
5401246 |
Mazur et al. |
Mar 1995 |
A |
5403337 |
Platts |
Apr 1995 |
A |
5411512 |
Abidin et al. |
May 1995 |
A |
5417704 |
Wonderley |
May 1995 |
A |
5423843 |
Werner |
Jun 1995 |
A |
5430942 |
Doucette |
Jul 1995 |
A |
5431631 |
Lu |
Jul 1995 |
A |
5431632 |
Lu |
Jul 1995 |
A |
5431671 |
Nallakrishman |
Jul 1995 |
A |
5431672 |
Cote et al. |
Jul 1995 |
A |
5470339 |
Lerrick |
Nov 1995 |
A |
5475925 |
Newman et al. |
Dec 1995 |
A |
5478346 |
Capewell |
Dec 1995 |
A |
5481804 |
Platts |
Jan 1996 |
A |
5489272 |
Wirtz |
Feb 1996 |
A |
5496340 |
Abdidin et al. |
Mar 1996 |
A |
5502896 |
Chen |
Apr 1996 |
A |
5507762 |
Abdidin et al. |
Apr 1996 |
A |
5522828 |
Malilay |
Jun 1996 |
A |
5527329 |
Gharibian |
Jun 1996 |
A |
5531705 |
Alter et al. |
Jul 1996 |
A |
5531754 |
Shackelford, Sr. et al. |
Jul 1996 |
A |
5533975 |
Lu |
Jul 1996 |
A |
5540660 |
Jenson |
Jul 1996 |
A |
5545175 |
Abidin et al. |
Aug 1996 |
A |
5556384 |
da Encarnacão |
Sep 1996 |
A |
5556409 |
Haining |
Sep 1996 |
A |
5562623 |
Shonfeld et al. |
Oct 1996 |
A |
5562624 |
Righi et al. |
Oct 1996 |
A |
5562626 |
Sanpietro |
Oct 1996 |
A |
5569203 |
Chen |
Oct 1996 |
A |
5569211 |
Lekhgolts et al. |
Oct 1996 |
A |
5569281 |
Abidin et al. |
Oct 1996 |
A |
5569282 |
Werner |
Oct 1996 |
A |
5571127 |
DeCampli |
Nov 1996 |
A |
5571128 |
Shapiro |
Nov 1996 |
A |
5572968 |
Esch et al. |
Nov 1996 |
A |
5575774 |
Chen |
Nov 1996 |
A |
5578015 |
Robb |
Nov 1996 |
A |
5599351 |
Haber et al. |
Feb 1997 |
A |
5601534 |
Turner |
Feb 1997 |
A |
5605544 |
Tsao |
Feb 1997 |
A |
5607402 |
Dufresne et al. |
Mar 1997 |
A |
5613951 |
Meyer et al. |
Mar 1997 |
A |
5613952 |
Pressly, Sr. et al. |
Mar 1997 |
A |
5620454 |
Pierce et al. |
Apr 1997 |
A |
5624408 |
Helldin |
Apr 1997 |
A |
5634903 |
Kurose et al. |
Jun 1997 |
A |
5634909 |
Schmitz |
Jun 1997 |
A |
5637092 |
Shaw |
Jun 1997 |
A |
5656031 |
Thorne et al. |
Aug 1997 |
A |
5658257 |
Ryles |
Aug 1997 |
A |
5662669 |
Abidin et al. |
Sep 1997 |
A |
5676677 |
Landis et al. |
Oct 1997 |
A |
5681292 |
Tober et al. |
Oct 1997 |
A |
5693023 |
Adams |
Dec 1997 |
A |
5702367 |
Cover et al. |
Dec 1997 |
A |
5722960 |
Duplan et al. |
Mar 1998 |
A |
5725501 |
Lichtenberg |
Mar 1998 |
A |
5730751 |
Dillon et al. |
Mar 1998 |
A |
5733261 |
Obong |
Mar 1998 |
A |
5749886 |
Abidin et al. |
May 1998 |
A |
5759177 |
Whisson |
Jun 1998 |
A |
5762628 |
Harper et al. |
Jun 1998 |
A |
5769822 |
McGary et al. |
Jun 1998 |
A |
5779724 |
Werner |
Jul 1998 |
A |
5782804 |
McMahon |
Jul 1998 |
A |
5785687 |
Saito |
Jul 1998 |
A |
5788677 |
Botich et al. |
Aug 1998 |
A |
5792107 |
Petrocelli |
Aug 1998 |
A |
5792162 |
Jolly et al. |
Aug 1998 |
A |
5797880 |
Erskine |
Aug 1998 |
A |
5800403 |
Pressly, Sr. et al. |
Sep 1998 |
A |
5810782 |
Saito |
Sep 1998 |
A |
5814017 |
Kashmer |
Sep 1998 |
A |
5820605 |
Zdeb et al. |
Oct 1998 |
A |
5827309 |
Jolly et al. |
Oct 1998 |
A |
5830226 |
Webb et al. |
Nov 1998 |
A |
5843107 |
Landis et al. |
Dec 1998 |
A |
5858000 |
Novacek et al. |
Jan 1999 |
A |
5868771 |
Herbert et al. |
Feb 1999 |
A |
5876382 |
Erickson |
Mar 1999 |
A |
5882342 |
Cooper et al. |
Mar 1999 |
A |
5885256 |
Chern et al. |
Mar 1999 |
A |
5885257 |
Badger |
Mar 1999 |
A |
5891092 |
Castellano |
Apr 1999 |
A |
5891105 |
Mahurkar |
Apr 1999 |
A |
5893844 |
Misawa |
Apr 1999 |
A |
5893845 |
Newby et al. |
Apr 1999 |
A |
5902271 |
Jentzen |
May 1999 |
A |
5902277 |
Jentzen |
May 1999 |
A |
5908432 |
Pan |
Jun 1999 |
A |
5919201 |
Carter et al. |
Jul 1999 |
A |
5921960 |
McGary et al. |
Jul 1999 |
A |
5928188 |
McGary et al. |
Jul 1999 |
A |
5935104 |
Janek et al. |
Aug 1999 |
A |
5938641 |
Villanueva |
Aug 1999 |
A |
5938675 |
Gharibian |
Aug 1999 |
A |
5938676 |
Cohn et al. |
Aug 1999 |
A |
5941892 |
Cohn et al. |
Aug 1999 |
A |
5944692 |
McGary et al. |
Aug 1999 |
A |
5968019 |
Lee |
Oct 1999 |
A |
5968020 |
Saito |
Oct 1999 |
A |
5971964 |
Donaldson |
Oct 1999 |
A |
5976111 |
Hart |
Nov 1999 |
A |
5980487 |
Jones et al. |
Nov 1999 |
A |
5980494 |
Malenchek et al. |
Nov 1999 |
A |
5984898 |
Garvin |
Nov 1999 |
A |
5989219 |
Villas et al. |
Nov 1999 |
A |
5993417 |
Yerfino et al. |
Nov 1999 |
A |
5993418 |
Alexander |
Nov 1999 |
A |
5993419 |
Lo et al. |
Nov 1999 |
A |
5997511 |
Curie et al. |
Dec 1999 |
A |
5998898 |
Fukutani et al. |
Dec 1999 |
A |
6010486 |
Carter et al. |
Jan 2000 |
A |
6013056 |
Pettersen |
Jan 2000 |
A |
6013059 |
Jacob |
Jan 2000 |
A |
6015396 |
Buttgen et al. |
Jan 2000 |
A |
6015419 |
Strome et al. |
Jan 2000 |
A |
6015438 |
Shaw |
Jan 2000 |
A |
6017325 |
Yerfino et al. |
Jan 2000 |
A |
6022364 |
Flumene et al. |
Feb 2000 |
A |
6033385 |
Liu |
Mar 2000 |
A |
6033386 |
Novacek et al. |
Mar 2000 |
A |
6036674 |
Caizza et al. |
Mar 2000 |
A |
6039713 |
Botich et al. |
Mar 2000 |
A |
6048354 |
Lawrence |
Apr 2000 |
A |
6050974 |
Allard et al. |
Apr 2000 |
A |
6050977 |
Adams |
Apr 2000 |
A |
6053929 |
Cohn et al. |
Apr 2000 |
A |
6066115 |
Lai |
May 2000 |
A |
6074370 |
Pressly, Sr. et al. |
Jun 2000 |
A |
6077244 |
Botich et al. |
Jun 2000 |
A |
6077245 |
Heinrich et al. |
Jun 2000 |
A |
6080461 |
Wozniak et al. |
Jun 2000 |
A |
6083199 |
Thorley et al. |
Jul 2000 |
A |
6083200 |
Grimm et al. |
Jul 2000 |
A |
6086568 |
Caizza |
Jul 2000 |
A |
6090077 |
Shaw |
Jul 2000 |
A |
6093170 |
Hsu et al. |
Jul 2000 |
A |
6093171 |
Huang |
Jul 2000 |
A |
6096005 |
Botich et al. |
Aug 2000 |
A |
6099500 |
Dysarz |
Aug 2000 |
A |
6102893 |
Aneas |
Aug 2000 |
A |
6102894 |
Dysarz |
Aug 2000 |
A |
6110147 |
Perouse |
Aug 2000 |
A |
6113617 |
van der Merwe |
Sep 2000 |
A |
6117112 |
Mahurkar |
Sep 2000 |
A |
6117113 |
Novacek et al. |
Sep 2000 |
A |
6120479 |
Campbell et al. |
Sep 2000 |
A |
6123688 |
Botich et al. |
Sep 2000 |
A |
6129710 |
Padgett et al. |
Oct 2000 |
A |
6132401 |
Van Der Meyden et al. |
Oct 2000 |
A |
6139526 |
Bedner et al. |
Oct 2000 |
A |
Foreign Referenced Citations (12)
Number |
Date |
Country |
2270509 |
Dec 1997 |
CN |
0347742 |
Dec 1989 |
EP |
0364387 |
Apr 1990 |
EP |
0405039 |
Jan 1991 |
EP |
0438368 |
Jul 1991 |
EP |
0480862 |
Apr 1992 |
EP |
WO8900432 |
Jan 1989 |
WO |
WO8909075 |
Oct 1989 |
WO |
WO9114465 |
Oct 1991 |
WO |
WO9209320 |
Jun 1992 |
WO |
WO9211883 |
Jul 1992 |
WO |
WO9218186 |
Oct 1992 |
WO |